ADMA Biologics (ADMA) News Today → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free ADMA Stock Alerts $9.52 +0.31 (+3.37%) (As of 10:39 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16, 2024 | americanbankingnews.comADMA Biologics, Inc. (NASDAQ:ADMA) Short Interest Up 7.5% in AprilMay 15, 2024 | marketbeat.comADMA Biologics (NASDAQ:ADMA) Hits New 12-Month High at $9.33ADMA Biologics (NASDAQ:ADMA) Sets New 52-Week High at $9.33May 14, 2024 | marketbeat.comRussell Investments Group Ltd. Acquires 236,255 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Russell Investments Group Ltd. lifted its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 62.7% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 613,032 shares of the biotechnology company's stock after acquiring an additional 236,255May 12, 2024 | seekingalpha.comGiving ADMA Biologics A Well-Deserved 'Booyah'May 12, 2024 | americanbankingnews.comADMA Biologics (NASDAQ:ADMA) PT Raised to $12.00 at MizuhoMay 12, 2024 | americanbankingnews.comHC Wainwright Increases ADMA Biologics (NASDAQ:ADMA) Price Target to $10.00May 12, 2024 | americanbankingnews.comADMA Biologics (NASDAQ:ADMA) PT Raised to $10.00May 12, 2024 | americanbankingnews.comADMA Biologics (NASDAQ:ADMA) PT Raised to $10.00 at Cantor FitzgeraldMay 11, 2024 | cnn.comADMA Biologics, Inc.May 11, 2024 | finance.yahoo.comADMA Biologics First Quarter 2024 Earnings: Beats ExpectationsMay 11, 2024 | americanbankingnews.comADMA Biologics (NASDAQ:ADMA) Shares Gap Up on Earnings BeatMay 10, 2024 | markets.businessinsider.comStrong Financial Performance and Growth Prospects Affirm Buy Rating for ADMA BiologicsMay 10, 2024 | marketwatch.comADMA Biologics Shares Rise 23% After 1Q Earnings Beat EstimatesMay 10, 2024 | msn.comADMA Biologics hits 52-week high on Q1 beat, guidance raiseMay 10, 2024 | finance.yahoo.comADMA Biologics Inc (ADMA) Surpasses Analyst Revenue and Earnings Forecasts in Q1 2024May 10, 2024 | finance.yahoo.comADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2024 Earnings Call TranscriptMay 10, 2024 | marketbeat.comADMA Biologics (NASDAQ:ADMA) Price Target Raised to $10.00Raymond James boosted their price target on shares of ADMA Biologics from $8.00 to $10.00 and gave the company a "strong-buy" rating in a research report on Friday.May 10, 2024 | marketbeat.comADMA Biologics (NASDAQ:ADMA) Releases Earnings Results, Beats Estimates By $0.03 EPSADMA Biologics (NASDAQ:ADMA - Get Free Report) released its quarterly earnings results on Thursday. The biotechnology company reported $0.08 earnings per share for the quarter, beating analysts' consensus estimates of $0.05 by $0.03. The company had revenue of $81.90 million for the quarter, compared to analysts' expectations of $77.28 million. ADMA Biologics had a positive return on equity of 0.49% and a negative net margin of 10.94%. The business's revenue for the quarter was up 43.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.03) earnings per share.May 10, 2024 | msn.comADMA Biologics Analysts Increase Their Forecasts After Upbeat ResultsMay 10, 2024 | marketbeat.comADMA Biologics (NASDAQ:ADMA) Shares Gap Up Following Strong EarningsADMA Biologics (NASDAQ:ADMA) Shares Gap Up After Strong EarningsMay 9, 2024 | chron.comAdma Biologics: Q1 Earnings SnapshotMay 9, 2024 | markets.businessinsider.comADMA Stock Earnings: ADMA Biologics Beats EPS, Beats Revenue for Q1 2024May 9, 2024 | marketbeat.comADMA Biologics (NASDAQ:ADMA) Hits New 1-Year High at $6.97ADMA Biologics (NASDAQ:ADMA) Sets New 52-Week High at $6.97May 9, 2024 | globenewswire.comADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business UpdateMay 8, 2024 | markets.businessinsider.comADMA Biologics is about to announce its earnings — here's what to expectMay 6, 2024 | msn.comChart of the Day: ADMA Biologics - Hitting New HighsMay 3, 2024 | marketbeat.comADMA Biologics (NASDAQ:ADMA) Reaches New 52-Week High at $6.80ADMA Biologics (NASDAQ:ADMA) Reaches New 12-Month High at $6.80May 3, 2024 | marketbeat.comADMA Biologics (ADMA) Set to Announce Quarterly Earnings on ThursdayADMA Biologics (NASDAQ:ADMA) will be releasing earnings after the market closes on Thursday, May 9, Zacks reports.May 2, 2024 | globenewswire.comADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024April 29, 2024 | marketbeat.comADMA Biologics, Inc. (NASDAQ:ADMA) Shares Purchased by PFG Investments LLCPFG Investments LLC increased its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 678.1% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 334,600 shares of the biotechnology company's stock after buApril 28, 2024 | seekingalpha.com3 'Buy-Rated' Biotech Stocks Under $10April 25, 2024 | finance.yahoo.comAdma Biologics (ADMA) Stock Moves -0.31%: What You Should KnowApril 22, 2024 | marketbeat.comCalamos Advisors LLC Has $1.13 Million Position in ADMA Biologics, Inc. (NASDAQ:ADMA)Calamos Advisors LLC boosted its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 122.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 250,185 shares of the biotechnology compaApril 16, 2024 | morningstar.comADMA Biologics IncApril 16, 2024 | marketbeat.comADMA Biologics (NASDAQ:ADMA) Shares Up 3.5%ADMA Biologics (NASDAQ:ADMA) Trading Up 3.5%April 15, 2024 | marketbeat.comADMA Biologics, Inc. (NASDAQ:ADMA) Sees Significant Decline in Short InterestADMA Biologics, Inc. (NASDAQ:ADMA - Get Free Report) was the target of a significant decrease in short interest in the month of March. As of March 31st, there was short interest totalling 7,290,000 shares, a decrease of 8.8% from the March 15th total of 7,990,000 shares. Based on an average daily trading volume, of 2,750,000 shares, the short-interest ratio is currently 2.7 days.April 15, 2024 | marketbeat.comDekaBank Deutsche Girozentrale Buys 220,000 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)DekaBank Deutsche Girozentrale raised its stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 1,359.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 236,178 shares of the biotechnology company's stock afterApril 12, 2024 | marketbeat.comPeregrine Capital Management LLC Acquires Shares of 882,983 ADMA Biologics, Inc. (NASDAQ:ADMA)Peregrine Capital Management LLC purchased a new position in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 882,983 shares of the biotechnology company's stock, valuedApril 10, 2024 | marketbeat.comVanguard Group Inc. Increases Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA)Vanguard Group Inc. boosted its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 2.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,781,695 shares of the biotechnology comApril 6, 2024 | marketbeat.comADMA Biologics, Inc. (NASDAQ:ADMA) Receives Average Recommendation of "Buy" from AnalystsADMA Biologics, Inc. (NASDAQ:ADMA - Get Free Report) has been given an average rating of "Buy" by the four ratings firms that are currently covering the stock, Marketbeat reports. Three research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the compaApril 3, 2024 | seekingalpha.comRising Margins And Product Promise Drive ADMA Biologics Forward (Rating Upgrade)April 1, 2024 | finance.yahoo.comInvestors in ADMA Biologics (NASDAQ:ADMA) have seen splendid returns of 261% over the past three yearsMarch 28, 2024 | marketbeat.comAssenagon Asset Management S.A. Trims Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA)Assenagon Asset Management S.A. trimmed its stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 21.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 3,945,225 shares of the biotechnology company's stock after selling 1,088,946 shares duringMarch 27, 2024 | marketbeat.comADMA Biologics (NASDAQ:ADMA) Sets New 12-Month High at $6.69ADMA Biologics (NASDAQ:ADMA) Hits New 12-Month High at $6.69March 27, 2024 | markets.businessinsider.comADMA Biologics Poised for Robust Growth: Buy Rating Affirmed with Enhanced Price TargetMarch 26, 2024 | markets.businessinsider.comA Closer Look at 6 Analyst Recommendations For ADMA BiologicsMarch 26, 2024 | marketbeat.comADMA Biologics' (ADMA) "Buy" Rating Reiterated at HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $7.50 price target (up previously from $6.00) on shares of ADMA Biologics in a research report on Tuesday.March 22, 2024 | marketbeat.comAmerican Century Companies Inc. Boosts Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)American Century Companies Inc. grew its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 20.8% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,892,123 shares of the biotechnology company's stMarch 21, 2024 | marketbeat.comADMA Biologics (NASDAQ:ADMA) Hits New 12-Month High at $6.44ADMA Biologics (NASDAQ:ADMA) Reaches New 1-Year High at $6.44March 20, 2024 | insidertrades.comInsider Selling: ADMA Biologics, Inc. (NASDAQ:ADMA) Director Sells 49,887 Shares of Stock Get ADMA Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Warren Buffett's "mystery stock" (Ad)WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some ADMA Media Mentions By Week ADMA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADMA News Sentiment▼0.270.42▲Average Medical News Sentiment ADMA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADMA Articles This Week▼44▲ADMA Articles Average Week Get ADMA Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NMRA News TARS News FDMT News INBX News FUSN News VIR News BEAM News CGEM News SRRK News DNA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADMA) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold4 Cryptos BETTER than BitcoinTrue Market InsidersDoes this make you sick?Allegiance GoldBill Gates is all about this tiny $2 stockTimothy SykesUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ADMA Biologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
